| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts
run for pharmaceutical analysts by pharmaceutical analysts
JPAG - PAST MEETINGS
RETURN TO MEETINGS
Thursday 13th May 2021
Biological potency
VIRTUAL EVENT : 1pm-3:30pm (UK BST)
Biological activity is a critical quality attribute for biological products. As this class of therapeutics expands and becomes more complex, with the growth of antibody-drug conjugates and cell and gene therapies for example, there are increasing challenges in developing scientifically relevant biological potency assays suitable for each stage of the product life cycle and, in particular, assays that are sufficiently robust for use in the GMP QC environment supporting clinical and commercial manufacturing.
This meeting will consider approaches to overcoming those challenges, including strategies for transitioning assays from R&D into the QC environment, application of new technologies to improve robustness of assays and methods for measuring the potency of cell therapies.
Speakers:
Dr Emma Bowen - Covance
Dr Monica Gunetti - OPBG
Dr Vijay Jethwa - Biologics Consulting
Dr Christiane Niederlaender - Parexel
Dr Ann Yellowlees - Quantics Biostatistics
Biological potency
VIRTUAL EVENT : 1pm-3:30pm (UK BST)
Biological activity is a critical quality attribute for biological products. As this class of therapeutics expands and becomes more complex, with the growth of antibody-drug conjugates and cell and gene therapies for example, there are increasing challenges in developing scientifically relevant biological potency assays suitable for each stage of the product life cycle and, in particular, assays that are sufficiently robust for use in the GMP QC environment supporting clinical and commercial manufacturing.
This meeting will consider approaches to overcoming those challenges, including strategies for transitioning assays from R&D into the QC environment, application of new technologies to improve robustness of assays and methods for measuring the potency of cell therapies.
Speakers:
Dr Emma Bowen - Covance
Dr Monica Gunetti - OPBG
Dr Vijay Jethwa - Biologics Consulting
Dr Christiane Niederlaender - Parexel
Dr Ann Yellowlees - Quantics Biostatistics
RETURN TO MEETINGS
WANT TO SEE MORE?
You will have access to materials for meetings that you have attended.
You will need to Sign In to activate access to your additional options.
Once Signed in, click on RESOURCES and look under MY PAST MEETINGS.
You will have access to materials for meetings that you have attended.
You will need to Sign In to activate access to your additional options.
Once Signed in, click on RESOURCES and look under MY PAST MEETINGS.
PAST MEETINGS
Symposium - October 2011
Delegates at a symposium held at the Royal Pharmaceutical Society
| Call us: | CONTACT US | Follow us: |     | Terms and Conditions Privacy Statement |
| © Joint Pharmaceutical Analysis Group 2021 Website by Delta Consultancy Services |
|